Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-09-05
2010-10-12
Yu, Misook (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S006120
Reexamination Certificate
active
07811778
ABSTRACT:
Methods for diagnosing an upper gastrointestinal (GI) cancer in a subject by determining an amount of one or more biomarkers in a biological sample from the subject are provided. Methods for determining whether to initiate or continue prophylaxis or treatment of an upper GI cancer in a subject by determining any measurable change in the amounts of the at least one biomarker in each of a series of biological samples provided over a time period are also provided.
REFERENCES:
patent: 6107048 (2000-08-01), Goldenring et al.
patent: 6235474 (2001-05-01), Feinberg
patent: 6372439 (2002-04-01), Goldenring et al.
patent: 6773890 (2004-08-01), Goldenring et al.
patent: 2001/0014459 (2001-08-01), Goldenring et al.
patent: 2002/0187487 (2002-12-01), Goldenring et al.
patent: 2003/0077675 (2003-04-01), Das
patent: 2003/0108965 (2003-06-01), Schummer et al.
patent: 2003/0170649 (2003-09-01), Haas et al.
patent: 2004/0033502 (2004-02-01), Williams et al.
patent: 2004/0235008 (2004-11-01), Sementchenko et al.
patent: 2005/0009067 (2005-01-01), Logsdon et al.
patent: 2005/0260639 (2005-11-01), Nakamura et al.
patent: 2006/0105333 (2006-05-01), Nakamura et al.
patent: 2006/0269921 (2006-11-01), Segara et al.
patent: 2009/0208514 (2009-08-01), Nakamura et al.
Zhu et al, Biochim Biophys Res Commun, 2000, 273:1019-1024.
Noguchi et al, Proc American Assoc Cancer Res Annual Meeting, Mar. 2004, 45:792.
Labouvie et al, J Cancer Res Clin Oncol, 1999, 125:71-76.
Nomura, et al., Spasmolytic Polypeptide Expressing Metaplasia to Preneoplasia in H. felis-Infected Mice, Gastroenterology, 2004, pp. 582-594, 127.
Galgano, et al., Comprehensive Analysis of HE4 Expression In Normal And Malignant Human Tissues, Modern Pathology, 2006, pp. 847-853, 19.
Halldorsdottir, et al., Spasmolytic polypeptide-expressing metaplasias (SPEM) associated with gastric cancer in Iceland, Digestive diseases and sciences, Mar. 2003, 48 (3), pp. 431-441.
Lee, et al, Differential protein analysis of spasomolytic polypeptide expressing metaplasias using laser capture microdissection and two-dimensional difference gel electrophoresis, AIMM, Jun. 2003, 11 (2), pp. 188-193.
Looijenga LH, Gillis AJ, van Gurp RJ, Verkerk AJ, Oosterhuis JW, X Inactivation in Human Testicular Tumors, XIST Expression and Androgen Receptor Methylation Status, Am J Pathol 1997; 151: 581-590.
Yamaguchi, et al., Association of spasmolytic polypeptide-expressing metaplasias with carcinogen administration and oxyntic atrophy in rats, Laboratory investigation; a journal of technical methods and pathology, Aug. 2002; 82 (* ), pp. 1045-1052.
Yamaguchi, et al., Identification of spasmolytic polypeptide expressing metaplasias (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies, Digestive diseases and sciences, Mar. 2002, 47 (3), pp. 573-580.
Chow, et al. Characterization of expression at the human XIST locus in somatic, embryonal carcinoma, and transgenic cell lines, Genomics, Sep. 2003, 82(3), pp. 309-322.
Aitola M, Sadek CM, Gustafsson JA, Pelto-Huikko M. Aint/Tacc3 is highly expressed in proliferating mouse tissues during development, spermatogenesis, and oogenesis. J Histochem Cytochem 2003;51:455-69.
Beauchamp RD, Barnard JA McCutchen CM, Cherner JA, Coffey RJ, Jr. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. J.Clin.lnvest. 1989;84:1017-1023.
Biankin, A.V., Kench, J.G., Dijkman, F.P., Biankin, S.A., and Henshall, S.M. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology 2003;35:14-24.
Bingle L, Singleton V, Bingle CD. The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene 2002;21:2768-73.
Blaser, M., and Parsonnet, J. Parasitism by the bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J.Clin.Invest. 1994;94:4-8.
Bouchard, D., Morisset, D., Bourbonnais, Y., and Tremblay, G.M. Proteins with whey-acidic-protein motifs and cancer. Lancet Oncol 2006;7:167-174.
Braun KA, Breeden LL. Nascent transcription of MCM2-7 is important for nuclear localization of the minichromosome maintenance complex in G1. Mol Biol Cell 2007;18:1447-56.
Cameron, A.J., Lomboy, C.T., Pera, M., and Carpenter, H.A. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-1546.
Correa P, A human Model of Gastric Carcinogenesis, Cancer Res 1988; 48:3554-3560.
Dhar, D.K., Wang, T.C., Maruyama, R., Udagawa, J., Kubota, H., Fuji, T., Tachibana, M., Ono, T., Otani, H., and Nagasue, N. Expression of cytoplasmic TFF2 is a biomarker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest 2003;83:1343-1352.
Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Barbosa J, Guilherme M, Moreira-Dias L, Lomba-Viana H, Silva R, Abreu N, Lomba-Viana R. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 2004; 6(5):449-56.
El-Zimaity, HMT, Ota, H, Graham, DY, Akamatsu, T, and Katsuyama, T. Patterns of gastric atrophy in intestinal type gastric carcinoma, Cancer 2002;94: 1428-36.
Filipe, M.I., Munoz, N., Matko, I., Kato, I., Pome-Kim, V., Juersek, A., Teuchmann, S., Benz, M., Prijon, T. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia, Int J Cancer. 1994;57: 324-329.
Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, Wang TC, Hypertrophic Gastropathy in Helicobacter felis-infected Wild Type C57BL16 Mice and p53 Hemizygous Transgenic Mice, Gastroenterology 1996; 110:155-166.
Goldenring JR, Poulsom R, Ray GS, Wright NA, Meise KS, Coffey RJ, Expression of Trefoil Peptides in the Gastric Mucosa of Transgenic Mice Overexpressing Transforming Growth Factor-a, Growth Factors 1996; 13:111-119.
Goldenring JR, Ray GS, Coffey RJ, Meunier PC, Haley P J, Barnes TB, Car BD, Reversible Drug-induced Xxyntic Atrophy in Rats, Gastroenterology 2000; 118:1080-1093.
Haggitt RC, Barrett's Esophagus, Dysplasia, and Adenocarcinoma, Hum Pathol 1994;25:982-993.
Hattori, T. Development of adenocarcinomas in the stomach. Cancer 1986;57:1528-1534.
Hellstrom, I., Raycraft, J., Hayden-Ledbetter, M., Ledbetter, J.A., Schummer, M., McIntosh, M., Drescher, C., Urban, N., and Hellstrom, K.E. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 2003;63:3695-3700.
Houghton J, Stoicov C, Nomura S, Carlson J, Li H, Rogers AB, Fox JG, Goldenring JR, Wang TC. Gastric cancer originating from bone marrow derived cells. Science 2004;In Press.
Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. III. Inward migration of neck cells followed by progressive transformation into zymogenic cells. Anat.Rec. 1993;236:297-313.
Kuipers EJ, Exploring the Link Between Helicobacter pylori and Gastric Cancer, Aliment Pharmacol Ther 1999; 13:3-11.
Leys CM, Nomura S, Rudzinski E, Kaminishi M, Montgomery E, Washington MK, Goldenring JR. Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol 2006;37:1162-8.
Means AL, Meszoely IM, Suzuki K, Miyamoto Y, Rustgi AK, Coffey RJ, Jr., Wright CV, Stoffers DA, Leach SD. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 2005;132:3767-76.
Mills JC, Andersson N, Hong CV, Stappenbeck TS, Gordon JI, Molecular Characterization of Mouse Gastric Epithelial Progenitor Cells, Proc Natl Acad Sci USA 2002; 99:14819-14824.
Nam KT, Varro A, Coffey RJ, Goldenring JR. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice. Gastroenterology 2007;132:1804-19.
Nomura, S., Settle, S.H., Leys, C., Means, A.L., Peek, R.M., Jr., Leach, S.D., Wright, C.V.E., Coffey, R.J., and Goldenring, J.R. Evidence for repatterning of the gastric fundic epithelium associated with Menetrier's disease and TGFa overexpression. Gastroenterology 2005;128:1292-
Decker Mandy Wilson
Halvorson Mark
Stites & Harbison PLLC
Vanderbilt University
Yu Misook
LandOfFree
Methods of screening for gastrointestinal cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of screening for gastrointestinal cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of screening for gastrointestinal cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4199575